Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Caribou Biosciences, Inc. publishes a filing, an earnings call transcript or a press release.

Get CRBU alerts

About Barbara McClung

The proxy statement of Caribou Biosciences, Inc. reports total compensation of $919,574 for Barbara McClung in fiscal 2025, including a base salary of $502,030. Disclosed compensation is on record for 5 fiscal years. Caribou Biosciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Caribou Biosciences, Inc. includes Rachel Haurwitz (CEO and Board Member), Sriram Ryali (CFO), Tim Kelly (CTO) and 7 others.

Affiliation history

Company network

Leadership on record at Caribou Biosciences, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Caribou Biosciences, Inc. (CRBU) $502,030 $919,574
2024 Caribou Biosciences, Inc. (CRBU) $485,053 $1,612,819
2023 Caribou Biosciences, Inc. (CRBU) $468,650 $1,217,807
2021 Caribou Biosciences, Inc. (CRBU) $414,432 $2,743,054
2020 Caribou Biosciences, Inc. (CRBU) $365,000 $504,150

Recent activity

No call appearances or filed executive changes recorded yet.